Finance
The company will use the funds to enrich its technology, commercialize its MRD product and continue the development of its multi-cancer early detection offering.
The company will use the funds to expand its reach throughout hospitals in the U.S. and enhance product development.
The company will use the funds to expand internationally, initially focused on the Japanese and Brazilian markets.
Data exchange platform Briya and clinical trial-participant management platform Mural Health also secured investments.
The funds will be used to develop AI-enabled ultrasound technology for maternal care and pediatric lung health in low- and middle-income countries.
The care delivery enablement platform scored $8 million and now has a foothold in New Jersey, Pennsylvania, Texas, Florida and Maryland.
Finalization of the deal is contingent upon approvals by state and regulatory authorities.
It was initially launched to help dispel the infodemic that ensued during the recent pandemic.
The deal comes less than a month after the company's plan to combine with digital neurotherapy company MindMaze fell through.
The raise brings the healthcare-focused firm's total committed capital to more than $1 billion.